Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Asit Parikh Insider Profile
4 Followers
Asit Parikh, Director at Phathom Pharmaceuticals, holds 22.50K shares in Phathom Pharmaceuticals (Ticker: PHAT). Most recently, Asit Parikh Bought $7,500 shares of Phathom Pharmaceuticals on Nov 08, 2023 for an estimated value of 58.58K.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+16.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Asit Parikh holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 16, 2022 - May 16, 2023
Return:+52.70%
The most profitable trade made by Asit Parikh
Asit Parikh's Trading History
List of latest transactions for each holding click on a transaction to see Asit Parikh's performance on stock
You May Also Like
Asit Parikh insider profile FAQ
What is the percentage of profitable transactions made by Asit Parikh?
The percentage of profitable transactions made by Asit Parikh is 80%.
What is the average return per transaction made by Asit Parikh?
The average return per transaction made by Asit Parikh is 16.50%.
What stocks does Asit Parikh hold?
Asit Parikh holds: PHAT stocks.
What was Asit Parikh’s latest transaction?
Asit Parikh latest transaction was an Informative Buy of $58.58K.
What was Asit Parikh's most profitable transaction?
Asit Parikh’s most profitable transaction was an Informative Buy of PHAT stock on May 16, 2022. The return on the trade was 52.70%.
What is Asit Parikh's role in Phathom Pharmaceuticals?
Asit Parikh's role in Phathom Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.